CA50 quantitative test kit

Cancer antigen 50, which is a glycoprotein mainly composed of sialic acid lipid and sialic acid glycoprotein, is also a tumor antigen. It is generally not present in normal tissues. When cells become malignant, glycosylase is activated, causing changes in the structure of cell surface glycosyls and becoming CA50 antigens. 94.4% of pancreatic cancers have elevated CA50. The flow fluorescent luminescence technology is upgraded to automation, which reduces the error and makes the detection result more accurate and stable.